Diffusion-Weighted MRI as a Quantitative Imaging Biomarker in Colon Tumors

Area of Science:

• Radiology
• Oncology
• Medical Imaging

Background:

• Colon cancer diagnosis relies on imaging and pathology.
• Distinguishing between benign adenomas and malignant tumors is crucial for treatment.
• Quantitative diffusion-weighted MRI (DW-MRI) offers potential for non-invasive tissue characterization.

Purpose of the Study:

• To evaluate quantitative DW-MRI as a biomarker for differentiating benign colon adenomas, early, and advanced colon cancer.
• To assess DW-MRI's ability to predict lymph node involvement.
• To compare mucinous colon cancer with adenomas and non-mucinous colon cancer.

Main Methods:

• 152 patients with colon tumors underwent MRI using a 3.0 Tesla machine.
• Mean apparent diffusion coefficient (mADC) was calculated for tumors.
• Tumor specimens were used for histopathological classification, with mucinous cancers assessed via T2 images.

Main Results:

• A significant difference in mADC was observed between colon adenomas and early colon cancer (p < 0.001), with an AUC of 0.80.
• A small but significant mADC difference was found between benign tumors and mucinous colon cancer (p = 0.039).
• No significant mADC differences were found between early and advanced colon cancer, or for lymph node involvement.

Conclusions:

• Quantitative DW-MRI shows promise in distinguishing benign colonic tumors from malignant ones.
• Mucinous colon cancer exhibits reduced diffusion restriction compared to non-mucinous types, which may impact diagnostic interpretation.